References
- 1. P. Brazis, J.C.. Masdeu, J. Biller, Localization in Clinical Neurology, 7th ed., Lippincott Williams & Wilkins (LWW), 2016.
- 2. J.D. England, G.S. Gronseth, G. Franklin, R.G. Miller, A.K. Asbury, G.T. Carter, et al., Distal symmetric polyneuropathy: A definition for clinical research -Report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation, Neurology. 64 (2005) 199207. https://doi.org/10.1212/01.WNL.0000149522.32823.EA.10.1212/01.WNL.0000149522.32823.EA
- 3. B.C. Callaghan, K.A. Kerber, L.L. Lisabeth, L.B. Morgenstern, R. Longoria, A. Rodgers, P. et al., Role of neurologists and diagnostic tests on the management of distal symmetric polyneuropathy, JAMA Neurol. 71 (2014) 11431149. https://doi.org/10.1001/jamaneurol.2014.1279.10.1001/jamaneurol.2014.1279
- 4. H.H. Schaumburg, S. Scelsa, S. Herskovitz, Peripheral Neuropathies in Clinical Practice, 1st editio, Oxford University Press, 2010.
- 5. D.A. Maranho, J.B. Volpon, ACQUIRED PES CAVUS IN CHARCOT-MARIE-TOOTH DISEASE, Rev. Bras. Ortop. (English Ed. 44 (2009) 479486. https://doi.org/10.1016/s2255-4971(15)30144-0.10.1016/S2255-4971(15)30144-0
- 6. C.W. Hicks, E. Selvin, Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes, Curr. Diab. Rep. 19 (2019) 18. https://doi.org/10.1007/s11892-019-1212-8.10.1007/s11892-019-1212-8675590531456118
- 7. P.J. Dyck, J.W. Albers, H. Andersen, J.C. Arezzo, G.J. Biessels, V. Bril, E.L. Feldman, et al., Diabetic polyneuropathies: Update on research definition, diagnostic criteria and estimation of severity, Diabetes. Metab. Res. Rev. 27 (2011) 620628. https://doi.org/10.1002/dmrr.1226.10.1002/dmrr.122621695763
- 8. S.C. Shin, J. Robinson-Papp, Amyloid neuropathies, Mt. Sinai J. Med. 79 (2012) 733748. https://doi.org/10.1002/msj.21352.10.1002/msj.21352353189623239211
- 9. S.S. Karne, N.S. Bhalerao, Carpal tunnel syndrome in hypothyroidism, J. Clin. Diagnostic Res. 10 (2016) OC36OC38. https://doi.org/10.7860/JCDR/2016/16464.7316.10.7860/JCDR/2016/16464.7316480056627042500
- 10. D. Adams, P. Lozeron, C. Lacroix, Amyloid neuropathies, Curr. Opin. Neurol. 25 (2012) 564572. https://doi.org/10.1097/WCO.0b013e328357bdf6.10.1097/WCO.0b013e328357bdf622941262
- 11. C. Alexander, M. Varacallo, Lumbosacral Radiculopathy Treatment & Management, StatPearls. (2017) 18.
- 12. S.P. Stabler, Clinical practice. Vitamin B12 deficiency., N. Engl. J. Med. 368 (2013) 14960. https://doi.org/10.1056/NEJMcp1113996.10.1056/NEJMcp111399623301732
- 13. Daroff, R. B., & Bradley, W. G. (2012). Bradley’s neurology in clinical practice. Philadelphia, PA: Elsevier/Saunders.
- 14. B. Giometto, W. Grisold, R. Vitaliani, F. Graus, J. Honnorat, G. Bertolini, J.C. et al., Paraneoplastic neurologic syndrome in the PNS euronetwork database: A European study from 20 centers, Arch. Neurol. 67 (2010) 330335. https://doi.org/10.1001/archneurol.2009.341.10.1001/archneurol.2009.34120212230
- 15. F. Blaes, Diagnosis and therapeutic options for peripheral vasculitic neuropathy, Ther. Adv. Musculoskelet. Dis. 7 (2015) 4555. https://doi.org/10.1177/1759720X14566617.10.1177/1759720X14566617435759225829955
- 16. P. Garcia de La Peña Lefebvre, L. Mouthon, P. Cohen, F. Lhote, L. Guillevin, Polyarteritis nodosa and mixed cryoglobulinaemia related to hepatitis B and C virus coinfection, Ann. Rheum. Dis. 60 (2001) 10681069. https://doi.org/10.1136/ard.60.11.1068.10.1136/ard.60.11.1068175340411602482
- 17. R.A. Rison, S.R. Beydoun, Paraproteinemic neuropathy: A practical review, BMC Neurol. 16 (2016). https://doi.org/10.1186/s12883-016-0532-4.10.1186/s12883-016-0532-4473193026821540
- 18. R. Zajaczkowsk¹, M. Kocot-Kêpska, W. Leppert, A. Wrzosek, J. Mika, J. Wordliczek, Mechanisms of chemotherapy-induced peripheral neuropathy, Int. J. Mol. Sci. 20 (2019). https://doi.org/10.3390/ijms20061451.10.3390/ijms20061451647166630909387
- 19. R. Pop-Busui, A.J.M. Boulton, E.L. Feldman, V. Bril, R. Freeman, R.A. Malik, J.M. Sosenko, D. Ziegler, Diabetic neuropathy: A position statement by the American diabetes association, Diabetes Care. 40 (2017) 136154. https://doi.org/10.2337/dc16-2042.10.2337/dc16-2042697740527999003
- 20. H. Garcia-Alcala, C.I. Santos Vichido, S. Islas Macedo, C.N. Genestier-Tamborero, M. Minutti-Palacios, O. Hirales Tamez,et al., Treatment with á-lipoic acid over 16 weeks in type 2 diabetic patients with symptomatic polyneuropathy who responded to initial 4-week high-dose loading, J. Diabetes Res. 2015 (2015). https://doi.org/10.1155/2015/189857.10.1155/2015/189857453945826345602
- 21. V. Bril, J. England, G.M. Franklin, M. Backonja, J. Cohen, D. Del Toro, et al., Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation, Neurology. 76 (2011) 17581765. https://doi.org/10.1212/WNL.0b013e3182166ebe.10.1212/WNL.0b013e3182166ebe310013021482920
- 22. NICE, Neuropathic pain?: the pharmacological management of neuropathic pain in adults in nonspecialist settings (NICE clinical, NICE Clin. Guidel. 96 (1997) 1104.
- 23. N. Attal, G. Cruccu, R. Baron, M. Haanpää, P. Hansson, T.S. Jensen, T. Nurmikko, EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision, Eur. J. Neurol. 17 (2010) 1113-e88. https://doi.org/10.1111/j.1468-1331.2010.02999.x.10.1111/j.1468-1331.2010.02999.x20402746
- 24. M. Sumitani, T. Sakai, Y. Matsuda, H. Abe, S. Yamaguchi, T. Hosokawa, S. Fukui, Executive summary of the Clinical Guidelines of Pharmacotherapy for Neuropathic Pain: second edition by the Japanese Society of Pain Clinicians, J. Anesth. 32 (2018) 463478. https://doi.org/10.1007/s00540-018-2501-0.10.1007/s00540-018-2501-0597395829737410
- 25. S. Tesfaye, S. Wilhelm, A. Lledo, A. Schacht, T. Tölle, D. Bouhassira, et al. Duloxetine and pregabalin: High-dose monotherapy or their combination? the “cOMBODN study” - A multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain, Pain. 154 (2013) 26162625. https://doi.org/10.1016/j.pain.2013.05.043.10.1016/j.pain.2013.05.04323732189